Ethyreal Bio

Cambridge, United States

Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.

$60.0M raised

Jan 2026

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ethyreal Bio raised?

Ethyreal Bio has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.

Who are Ethyreal Bio's investors?

Ethyreal Bio's investors include Atlas Venture, Medicxi, Avoro Capital Advisors, Nandi Life Sciences LLC, Checkpoint Capital.

Where is Ethyreal Bio headquartered?

Ethyreal Bio is headquartered in Cambridge, United States.

What does Ethyreal Bio do?

Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.

What stage is Ethyreal Bio at?

Ethyreal Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2026.

MLA

"Ethyreal Bio — Funding & Investors." VCBacked, January 1, 2026, https://www.vcbacked.co/company/ethyreal-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). Ethyreal Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ethyreal-bio

Wikipedia (cite web)

{{cite web |title=Ethyreal Bio — Funding & Investors |url=https://www.vcbacked.co/company/ethyreal-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2026.